Abstract: The invention provides a semiconductor cleaning step, which comprises the following steps: providing a chamber with a bottom surface and a sidewall, the chamber contains a heater on the bottom surface, performing a first deposition step to leave a residual layer on the sidewall of the chamber, performing a carbon deposition step to form a carbon layer on at least the surface of the heater, and performing a plasma cleaning step to simultaneously remove the residual layer on the sidewall of the chamber and the carbon layer on the bottom surface.

Abstract: Fabricating a semiconductor substrate by (a) vertical etching a feature having sidewalls and a depth into one or more layers formed on the semiconductor substrate and (b) depositing an amorphous carbon liner onto the sidewalls of the feature. Steps (a) and optionally (b) are iterated until the vertical etch feature has reached a desired depth. With each iteration of (a), the feature is vertical etched deeper into the one or more layers, while the amorphous carbon liner resists lateral etching of the sidewalls of the feature. With each optional iteration of (b), the deposited amorphous carbon liner on the sidewalls of the feature is replenished.

Abstract: A multidimensional knowledge transfer model for predicting CTR of a computational ad, the multidimensional knowledge transfer model comprises: a pre-processor for building an ad group node graph based on similarities among ad group nodes, an ad campaign node graph from merging the ad group node graph, and an ad account node graph from merging the ad campaign node graph. The multidimensional knowledge transfer model further comprises a multi-knowledge CTR prediction model for each of the ad account, ad campaign, and ad group layers. The multi-knowledge CTR prediction model predicts the respective node's CTR from the ad account node graph, ad campaign node graph, or ad group node graph, features of the audience group, and features of the node having its CTR predicted appended with the hidden vector of its parent node extracted from the upper layer multi-knowledge CTR prediction model.

Abstract: This disclosure describes an exhaust assembly that includes an exhaust tube and a coolant passage. The exhaust tube is oriented about an axis and an exhaust gas is configured to flow through the exhaust tube in a direction away from an end of the exhaust tube. The coolant passage is oriented about the axis radially outward of the exhaust tube, the coolant passage having an inner shell and an outer shell. The exhaust assembly further includes an expansion reservoir positioned vertically (relative to a gravitational reference) above the coolant passage. The expansion reservoir and coolant passage are fluidly coupled by a conduit having a first diameter. The expansion reservoir is coupled with a coolant reservoir by a second conduit having a diameter less than the first diameter. Vapor after a hot shutdown travels up the first conduit and is replaced by coolant flowing down the first conduit.

Abstract: The present disclosure is directed to a patterned stiffener that includes a metallic body, which is a component of and is attached to a semiconductor device platform for providing rigidity. In an aspect, there are patterned sections formed on the metallic body that act to modulate the metallic body to obtain a desired configuration for the semiconductor device platform. In another aspect, the present disclosure is also directed to a method that includes providing a platform for forming an electronic component, disposing a stiffener having a metallic body on the platform, disposing at least one semiconductor device onto the platform, performing one or more bonding process steps, and exposing the stiffener to localized heating to modulate changes in the stiffener to a pre-determined shape or desired configuration.

Abstract: The disclosure relates to the technical field of preparing the metal material of magnesium alloy, and particularly provides a method for preparing biomedical magnesium alloy wires. The magnesium, zinc, and neodymium alloys are subject to smelting, casting, rolling, and other processes to prepare plates. The plates are subjected to a special mechanical stirring process to prepare a processing zone with the same thickness as the plates. After machining, the processing zone is used as the final product of the wire or drawn in multiple passes to finally form the wire with the required diameter.

Abstract: Described herein is N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(R)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide (Compound A) (Formula I), including crystalline forms, solvates, and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions or pharmaceutical formulations that include the compound, as well as methods of using the compound, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, diabetes, and inflammatory diseases or conditions.

Abstract: Clock calibration adjustments are provided. Some embodiments disclosed herein are related to a device. A device can include a first conductive element configured to receive a first signal at a first functional block. The device can include a second conductive element configured to convey the first signal to a second functional block of the device. The device can include a third conductive element to receive a second signal from the second functional block, the second signal varying from the first signal according to a phase-shift. The device can include a first circuit configured to determine the phase-shift between the first signal and the second signal. The device can include a second circuit configured to generate a third signal based on the phase-shift, the first signal, the second signal.

Abstract: Methods and apparatus are disclosed herein to center a steering wheel. An example vehicle includes a steering assistance system, an axle including a wheel, memory, and a processor to execute instructions to identify a first position of the wheel, detect a request to move the wheel to a second position, adjust the wheel from the first position to the second position via the steering assistance system, disengage the steering assistance system, the disengagement of the steering assistance system to cause the wheel to move to a third position, the third position offset from the second position by an angular offset in a first direction, adjust the wheel to a fourth position, the fourth position offset from the second position by the angular offset in a second direction different than the first direction, and disengage the steering assistance system, the disengagement of the steering assistance system to cause the wheel to move to the second position.

Abstract: A hardware fault detection method includes, after performing error correction on data at a target location in an internal memory and writing corrected data into the target location, the internal memory controller reads first data from the target location. When determining that an error exists in the first data, the internal memory controller reports an error message, where the error message indicates that a hardware fault occurs at the target location. After finding that an error occurs in the data at the target location, the internal memory controller performs the error correction, write-back, and re-reading on the data, to further determine a type of the error occurring at the target location.

Abstract: Methods and apparatus are disclosed herein to center a steering wheel. An example vehicle includes a steering assistance system, an axle including a wheel, memory, and a processor to execute instructions to identify a first position of the wheel, detect a request to move the wheel to a second position, adjust the wheel from the first position to the second position via the steering assistance system, disengage the steering assistance system, the disengagement of the steering assistance system to cause the wheel to move to a third position, the third position offset from the second position by an angular offset in a first direction, adjust the wheel to a fourth position, the fourth position offset from the second position by the angular offset in a second direction different than the first direction, and disengage the steering assistance system, the disengagement of the steering assistance system to cause the wheel to move to the second position.

Abstract: Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of NLRP3 and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by NLPR3. The compounds of the present invention may be useful in the treatment, prevention or management of diseases, disorders and conditions mediated by NLRP3 such as, but not limited to, gout, pseudogout, CAPS, NASH fibrosis, heart failure, idiopathic pericarditis, atopic dermatitis, inflammatory bowel disease, Alzheimer's Disease, Parkinson's Disease and traumatic brain injury.

Abstract: Methods, apparatus, systems and articles of manufacture are disclosed. An example vehicle disclosed herein includes a steering assist system, a steering wheel, and a steering controller to detect a request to move the steering wheel of the vehicle to a first rotational position, the steering wheel having a second rotational position, actuate, via the steering assist system, the steering wheel towards the first rotational position, determine, based on a relationship between a first parameter and a second parameter, a third rotational position, the third rotational position having an angular offset from the first rotational position, the first parameter corresponding to a position of the steering system, the second parameter corresponding to a load on the steering system, and in response to reaching the third rotational position, disengage the steering assist system, the disengagement causing the steering wheel to rotate to the first rotational position.

Abstract: The present invention relates to novel Fused Bicyclic Pyrazole Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. The present invention also relates to compositions comprising at least one Fused Bicyclic Pyrazole Derivative, and methods of using the Fused Bicyclic Pyrazole Derivatives for treating or preventing a herpesvirus infection in a patient.

Abstract: A primer set for detecting telomerase activity, the primer set including a first primer set or a second primer set. The first primer set includes: an upstream primer selected from MTS; and a downstream primer selected from the group consisting of ACX-M4, Beacon ACX62-2C, and Beacon ACX62-10. The second primer set includes: an upstream primer selected from STS or CTS; and a downstream primer selected from the group consisting of ACX, CXT, ACX-M4, Beacon ACX62-2C, or Beacon ACX62-10. The sequences of the primers ACX, CXT, ACX-M4, Beacon ACX62-2C, Beacon ACX62-10, STS, CTS and MTS are shown as SEQ ID NOs: 1 to 8, respectively.

Abstract: Provided is a co-attrited MCC/CMC stabilizer composition containing MCC made from non-dissolving cellulose pulps that is useful for stabilizing plant protein based drinks. Also provided are plant protein drink compositions stabilized using the co-attrited MCC/CMC stabilizer composition containing MCC made from non-dissolving cellulose pulps. Also provided are methods of stabilizing plant protein drink compositions using the co-attrited MCC/CMC stabilizer composition containing MCC made from non-dissolving cellulose pulps.

Abstract: A polypeptide probe for detecting G-quadruplexes (G4s), includes: from two to four G4-binding domains, and one or more linkers disposed between every two G4-binding domains. Each G4-binding domain includes a specific motif including a sequence of amino acids PGHLKGREIGMWY (SEQ ID NO: 1).

Abstract: Novel compounds of the structural formula I, and the pharmaceutically acceptable salts thereof, are inhibitors of TarO and may be useful in the prevention, treatment and suppression of diseases mediated by TarO, such as bacterial infections, including gram negative bacterial infections and gram positive bacterial infections such as MRSA and MRSE, alone or in combination with a ?-lactam antibiotic.

Abstract: Novel compounds of the structural formula I, and the pharmaceutically acceptable salts thereof, are inhibitors of TarO and may be useful in the prevention, treatment and suppression of diseases mediated by TarO, such as bacterial infections, including gram negative bacterial infections and gram positive bacterial infections such as MRSA and MRSE, alone or in combination with a ?-lactam antibiotic.

Abstract: Methods, apparatus, systems and articles of manufacture are disclosed. An example vehicle disclosed herein includes a steering assist system, a steering wheel, and a steering controller to detect a request to move the steering wheel of the vehicle to a first rotational position, the steering wheel having a second rotational position, actuate, via the steering assist system, the steering wheel towards the first rotational position, determine, based on a relationship between a first parameter and a second parameter, a third rotational position, the third rotational position having an angular offset from the first rotational position, the first parameter corresponding to a position of the steering system, the second parameter corresponding to a load on the steering system, and in response to reaching the third rotational position, disengage the steering assist system, the disengagement causing the steering wheel to rotate to the first rotational position.